Dr. Qiang Feng 冯强
Chief Physician
Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Laparoscopic surgery for rectal and colon cancer, including low and ultra-low sphincter-preserving procedures and NOSES. Treatment of gastrointestinal stromal tumors. Focus on preserving sexual and urinary function, particularly in elderly patients.
Dr. Feng holds a PhD from Peking Union Medical College and serves as a master’s supervisor there. A Chief Physician, Dr. Feng has performed over 3,000 colorectal surgeries. In 2021, Dr. Feng served as Deputy Director of Qinghai Cancer Hospital, leading complex laparoscopic NOSES procedures and establishing a multidisciplinary tumor diagnosis and treatment center.
Professional roles
- Vice Chair, Tumor Risk Assessment and Systematic Intervention Professional Committee, China Health Care Association
- Member, Family Hereditary Tumor Professional Committee, China Anti-Cancer Association
- Member, Colorectal Physicians Branch, Chinese Medical Doctor Association
- Standing Committee Member, Science Popularization Branch, China Medicine Promotion Association
Name order: in Chinese the family name comes first (Feng Qiang). Papers usually list the name as Qiang Feng or Feng Q.
Selected publications
25 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Transl Cancer Res, 2025 (senior author): Development and validation of nomograms for predicting survival of locally advanced rectosigmoid junction cancer patients: a SEER database analysis. PubMed 40530120
- Transl Cancer Res, 2025 (senior author): Development and validation of survival prediction nomograms for patients with early-stage rectal cancer: a population-based study. PubMed 40386280
- Transl Cancer Res, 2025 (senior author): Development and validation of predictive nomograms for survival in early-onset colon cancer patients with II-III stage across various tumor sites. PubMed 40386271
- BMC Gastroenterol, 2023 (senior author): Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study. PubMed 37865754
- Ann Transl Med, 2022 (senior author): Clostridium butyricum inhibits the progression of colorectal cancer and alleviates intestinal inflammation via the myeloid differentiation factor 88 (MyD88)-nuclear factor-kappa B (NF-κB) signaling pathway. PubMed 35571406
- Cancer Cell Int, 2021 (first author): CDC42EP3 promotes colorectal cancer through regulating cell proliferation, cell apoptosis and cell migration. PubMed 33726765
- Chin Med J (Engl), 2020 (senior author): Clinicopathological characteristics and prognostic factors for the recurrence of abdominal desmoid tumors: a retrospective study of 113 patients from two Chinese hospitals. PubMed 34134126
- Cancer Manag Res, 2020 (senior author): Lobaplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastasis from Appendiceal and Colorectal Cancer: Safety and Efficacy Profiles. PubMed 33262658
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion